Arterys Cardio DL vs iCAC Device
AI Verdict
Choose Arterys Cardio DL if…
Choose Arterys Cardio DL if your primary need is advanced, detailed analysis of cardiac MRI studies. This tool is ideal for clinicians requiring automated, editable ventricle segmentations, 4D Flow post-processing, and quantitative delayed enhancement analysis to precisely assess cardiac function and pathology. It significantly reduces interpretation time for complex MRI data, enhancing diagnostic accuracy for comprehensive cardiac evaluations.
View Arterys Cardio DL →Choose iCAC Device if…
Choose iCAC Device if your goal is opportunistic screening and quantification of coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans. This tool is best suited for identifying cardiovascular disease risk in a broader patient population by leveraging existing imaging data, providing valuable adjunctive information to radiologists and aiding in early detection without requiring specialized cardiac CT protocols.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Arterys Cardio DL | iCAC Device |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Arterys Cardio DLArterys Cardio DL offers automated, editable ventricle segmentations for cardiac MRI, significantly reducing interpretation time and providing user control through editable contours. Its rapid analysis (seconds vs. 30-60 minutes) directly enhances workflow efficiency.
Clinical Value
iCAC DeviceWhile both are FDA-cleared and offer significant clinical benefits, Bunkerhill Health's iCAC Device provides a unique clinical value by opportunistically detecting and quantifying coronary artery calcium from routine, non-contrast, non-gated chest CT scans. This allows for early cardiovascular disease detection in a broader patient population without requiring dedicated cardiac imaging.
Pricing & Value
TieBoth tools require contacting the vendor for pricing, making direct comparison of pricing transparency and cost-effectiveness difficult. Neither provides specific pricing details in the provided information.
Enterprise Readiness
Arterys Cardio DLArterys Cardio DL explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available, which are critical for enterprise adoption and data security. In contrast, Bunkerhill Health's iCAC Device states 'Contact vendor for details' for BAA and HIPAA compliance, indicating less upfront transparency on these crucial enterprise requirements.
Innovation
iCAC DeviceWhile Arterys Cardio DL was a pioneer in cloud-based medical imaging with deep learning for cardiac MRI, Bunkerhill Health's iCAC Device demonstrates significant innovation by enabling opportunistic screening for coronary artery calcium from existing, routine chest CT scans. This approach leverages readily available data for proactive cardiovascular risk assessment, representing a novel application of AI in population health.
Support & Docs
Arterys Cardio DLArterys provides a dedicated 'Support' section on its website, offering information on training, technical support, professional services, and a knowledge base. Bunkerhill Health's website, while providing contact information, does not prominently feature a dedicated support or documentation section, suggesting less readily available public support resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Arterys Cardio DL | iCAC Device |
|---|---|---|
| Name | Arterys Cardio DL | iCAC Device |
| Company | ARTERYS | Bunkerhill Health |
| Description | FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy. | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Radiology | Cardiology, Radiology |
| Key Features | Automated ventricle segmentations for cardiac MRI, Deep learning algorithms for image analysis, Cloud-based platform for accessibility and performance, Vendor-agnostic compatibility, Rapid analysis (seconds vs. 30-60 minutes), Editable automated contours, 4D Flow post-processing for blood flow visualization and quantification, Quantitative Delayed Enhancement analysis. | Estimates presence and quantity of coronary artery calcium (CAC), Analyzes routine, non-contrast, non-gated chest CT scans, Utilizes deep-learning algorithms for analysis, Provides adjunctive information to radiologists, Outputs visual representation of estimated CAC segmentation, Delivers exact and four-category quantitative estimates of CAC burden in Agatston units, Integrates with EHRs via the Carebricks platform, Supports opportunistic identification of CAC from existing CT scans. |
Videos
Demos, reviews, and walkthroughs featuring Arterys Cardio DL and iCAC Device.